Northwest Biotherapeutics (NWBO) Return on Capital Employed Growth (1y) (2012 - 2026)
Northwest Biotherapeutics (NWBO) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 2,400.00 |
| 10 | Northwest Biotherapeutics | 274.18 Mn | 272.39 Mn | - | 220,200.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220,200.00 |
| Dec 31, 2025 | 235.00 |
| Sep 30, 2025 | -9,285.00 |
| Jun 30, 2025 | -10,579.00 |
| Mar 31, 2025 | -4,863.00 |
| Dec 31, 2024 | -19,229.00 |
| Sep 30, 2024 | -3,682.00 |
| Jun 30, 2024 | -42,702.00 |
| Mar 31, 2024 | -36,778.00 |
| Dec 31, 2023 | 28,666.00 |
| Sep 30, 2023 | 17,318.00 |
| Jun 30, 2023 | 57,251.00 |
| Mar 31, 2023 | 49,008.00 |
| Dec 31, 2022 | 1,795.00 |
| Sep 30, 2022 | 4,570.00 |
| Jun 30, 2022 | 4,707.00 |
| Mar 31, 2022 | 1,827.00 |
| Dec 31, 2021 | 2,835.00 |
| Sep 30, 2021 | -1,106.00 |
| Jun 30, 2021 | -622.00 |